VAERS reports by lot

Pfizer COVID-19 lot HG2282: VAERS reports

61 VAERS reports list lot HG2282 as a Pfizer COVID-19 vaccine, received between 2023-09-29 and 2024-09-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
61
Reports
15%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular3619%
Gastrointestinal2815%
General / Systemic (non-local)2815%
Neurological2715%
Injection-site / Local reaction2413%
Respiratory105%
Dermatological (non-injection-site)95%
Musculoskeletal84%
Allergic / Anaphylactic53%
Psychiatric / Neuropsychiatric42%
Autoimmune / Immune-mediated32%
Thrombotic / Hematological21%
Reproductive / Menstrual11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California12
Illinois5
New York4
Georgia3
Missouri3
Texas2
Massachusetts2
Michigan2
Maryland2
Arkansas2
Virginia2
Florida1

Reports by month received

2023-091
2023-1016
2023-1116
2023-1212
2024-014
2024-023
2024-034
2024-041
2024-063
2024-091

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.